Global Bio Similars/Subsequent Entry Biologic Market Impact of AI and Automation

Bio Similars/Subsequent Entry Biologic Market Impact of AI and Automation The global market for biosimilars and subsequent entry biologics was valued at approximately $9.4 billion in 2022, with a compound annual growth rate (CAGR) of around 22.5%. This robust growth trajectory is driven by increasing demand for affordable biologic treatments, as well as advancements in… Continue reading Global Bio Similars/Subsequent Entry Biologic Market Impact of AI and Automation